Phil has an executive background in marketing and transformation including 20 years experience with MARS and Shell. He has been a Board Director for 11 years and now has a range of non-executive directorships including RCU, an education consultancy which he chairs and the Agricultural and Horticultural Development Board.
In NHS terms, Phil has been with the Manchester Primary Care Trust board, Alder Hey Children’s Hospital and now Liverpool Women’s Hospital.
Dr Peter Williams is the NHS Transformation Unit Non-Executive Medical Director.
Peter held several junior doctor roles and worked as a kidney research fellow before becoming a senior registrar in nephrology at the Royal Liverpool University Hospital. With several years in Manchester as a consultant he returned to Liverpool in 1997 as a consultant nephrologist.
He has since remained at the Trust taking on a variety of roles including clinical director for general internal medicine, divisional medical director and most recently, medical director.
Susan is a director of strategic change, whose career has spanned financial and consultancy roles, culminating with British Telecom where she was also a member of its NW Regional Board.
A former chair of pro-Manchester, Susan is currently a trustee of HOME, director of Manchester Communication Academy and public governor of Central Manchester University NHS Hospitals Foundation Trust.
Susan is an independent project manager and a regular presenter for Women on Boards UK in Manchester and Leeds.
John is a mathematics graduate of the University of Nottingham. John trained as a Chartered Accountant, he become a member of the Chartered Institute of Tax and partner in PricewaterhouseCoopers.
John retired from the firm in 2005 having run part of the regional and national businesses. He is Deputy Chairman of Matalan having been Chairman for six years, a Director of a number of private companies, President of the University of Nottingham Council and Chairman of Torch Academy Gateway Trust.
Chris is a PhD biochemist from the University of Georgia who spent his career in pharmaceutical R&D. He was the Global VP and Head of Project Evaluation at AstraZeneca from 2005 to 2011 where he also led AZ’s research strategy, business plan and performance improvement activities. He worked in healthcare venture capital at Advent International (Boston) from 2003 to 2005.
Chris advises biotechs, Venture Capital companies, medical charities and academics. He is a Professor of Practice at KCL and a Board member of the Medicines Discovery Catapult and Northern Care Alliance (Salford Royal NHS Foundation Trust and Pennine Acute Care NHS Trust).
Enter your Email address to subscribe to our newsletter.